This content is machine translated Recurrent ovarian cancer Current developments give hope for a personalized approach At the ESMO Congress in Amsterdam, a review was given of the options available to date in the treatment of recurrent ovarian cancer. Therapy depends on the particular form of…
View Post 13 min This content is machine translated Folic acid as a dietary supplement The multiple health benefits of adequate folic acid intake In order to assess the appropriate use of folic acid as a supplement or its fortification in foods, it is necessary to know the biological importance, the supply of the…
View Post 10 min This content is machine translated Treatment of epithelial ovarian cancer. Slow but steady progress Epithelial ovarian carcinoma is a heterogeneous group of carcinomas that have different etiology, genetics, and thus biological prognosis. In advanced stages (IIB-IV), the standard therapy remains maximal cytoreductive therapy, weighing…
View Post 7 min This content is machine translated HER2-positive breast carcinoma New substances enable targeted therapy The HER2 receptor belongs to the family of four transmembrane receptor tyrosine kinases (EGFR/HER1, HER2, HER3, and HER4) that influence cell growth, differentiation, and survival. Overexpression of HER2 occurs in…
View Post 3 min This content is machine translated Female tumors From the “old-fashioned” CMF to the modern T-DM1 Over the past two decades, the prognosis of breast carcinoma has improved significantly. As a rule, 75% of patients are cured today. The introduction of modern chemotherapeutic agents, particularly taxanes,…
View Post 5 min This content is machine translated Incontinence “The Internet is a good medium for providing information about taboo subjects” In an interview with HAUSARZT PRAXIS, PD Dr. med. André Reitz of the KontinenzZentrum Hirslanden, Zurich, provides information about his blog kontinenzzentrum.blogspot.ch, which he has been running since summer 2013.…
View Post 4 min This content is machine translated HER2-positive breast cancer and lymphoma New applications and antibodies The antibody-drug conjugate trastuzumab emtansine, T-DM1 (Kadcyla®), is composed of the antibody trastuzumab and the chemotherapeutic agent DM1 and is currently being investigated for the treatment of HER2-positive cancers. It…
View Post 8 min This content is machine translated 100 years of dermatology at Triemli From the “Tièche” Clinic to the Dermatological Outpatient Clinic “In literature, art and music, extremes are being pushed to the limit as if there were no tomorrow” – this is how Florian Illies’ current bestseller portrays the monstrous year…
View Post 9 min This content is machine translated Recurrent cystitis Multimodal concept instead of monotherapy with antibiotics Recurrent cystitis in women of all ages is becoming an increasing problem in practice – not because of antibiotic resistance, but because of constantly re-ascending host intestinal and skin bacteria.…
View Post 3 min This content is machine translated Folic acid Better informed about the prevention of spina bifida At the annual meeting of the Folic Acid Offensive Switzerland, various speakers from medicine and science discussed the local supply situation and possible opportunities for improvement. In particular, the lack…
View Post 3 min This content is machine translated College breast cancer Seal for high-quality and practice-oriented training for five years now Under the label Kollegium Brustkrebs, a continuing education platform for specialists interested in breast cancer was created in 2008. The platform is characterized by a high level of quality and…
